Carbonic anhydrase II deficiency

Carbonic Anhydrase II Deficiency is a rare genetic disorder characterized by the malfunction of the enzyme carbonic anhydrase II. This enzyme plays a crucial role in various bodily processes, including the regulation of pH levels in blood and tissues, the transport of carbon dioxide (CO2) in the blood, and the formation of bicarbonate ions, which are essential for maintaining acid-base balance in the body. The deficiency of carbonic anhydrase II leads to a range of clinical manifestations, including osteopetrosis, renal tubular acidosis (RTA), and cerebral calcification.

Causes

Carbonic anhydrase II deficiency is caused by mutations in the CA2 gene, which provides instructions for making the carbonic anhydrase II enzyme. These mutations lead to either a reduction in enzyme activity or the production of a nonfunctional enzyme. The disorder is inherited in an autosomal recessive pattern, meaning that an individual must receive a mutated gene from both parents to be affected.

Symptoms

The symptoms of carbonic anhydrase II deficiency can vary widely among affected individuals but commonly include:

• Osteopetrosis: A condition characterized by the abnormal hardening and densification of bone, leading to bone fragility.
• Renal Tubular Acidosis: A disorder in which the kidneys fail to properly acidify the urine, leading to an imbalance of acid levels in the blood.
• Cerebral Calcification: The accumulation of calcium in the brain, which can affect neurological functions.

Other symptoms may include growth retardation, intellectual disability, and dental anomalies.

Diagnosis

Diagnosis of carbonic anhydrase II deficiency typically involves a combination of clinical evaluation, family history, and genetic testing to identify mutations in the CA2 gene. Imaging studies, such as X-rays or MRI, may be used to assess bone density and detect cerebral calcification. Blood and urine tests can help evaluate the acid-base balance and kidney function.

Treatment

There is no cure for carbonic anhydrase II deficiency, and treatment focuses on managing symptoms and preventing complications. Therapies may include:

• Bicarbonate supplements: To help correct acid-base imbalances.
• Phosphate supplements: To address bone mineralization defects.
• Vitamin D: To support bone health.
• Potassium citrate: To prevent kidney stones.

In some cases, bone marrow transplantation has been explored as a treatment for osteopetrosis associated with carbonic anhydrase II deficiency.

Prognosis

The prognosis for individuals with carbonic anhydrase II deficiency varies depending on the severity of symptoms and the effectiveness of management strategies. Early diagnosis and treatment can improve the quality of life and reduce the risk of complications.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian